Related Experiment Video
Updated: Jun 27, 2026
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Published on: July 12, 2021
[Clinical features and SCN1A gene mutation analysis of severe myoclonic epilepsy of infancy]
Yue-hua Zhang1, Hui-hui Sun, Xiao-yan Liu
1Department of Pediatrics, First Hospital, Peking University, Beijing 100034, China.
Insights
Severe myoclonic epilepsy of infancy (SMEI), or Dravet syndrome, typically begins before one year of age with febrile seizures. Genetic testing for SCN1A mutations aids early diagnosis and guides treatment for this severe epileptic encephalopathy.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Context:
- Severe myoclonic epilepsy of infancy (SMEI), also known as Dravet syndrome, is a debilitating epileptic encephalopathy in children.
- Early identification and understanding of clinical manifestations are crucial for effective management.
Purpose:
- To investigate the clinical characteristics and genetic underpinnings of SMEI in a cohort of 13 children.
- To analyze the correlation between SCN1A gene mutations and the clinical presentation of SMEI.
Summary:
- The study analyzed 13 children with SMEI, revealing seizure onset typically before one year, often starting with febrile seizures and progressing to multiple seizure types.
- Key features included temperature sensitivity, developmental delay, and characteristic EEG changes. SCN1A gene mutations were identified in 10 patients.
- Treatment challenges were noted, with some antiepileptic drugs exacerbating seizures, highlighting the need for precise diagnosis.
Impact:
- This research underscores the importance of early SCN1A mutation testing for accurate diagnosis of SMEI.
- Findings guide the selection of appropriate antiepileptic drugs, potentially improving patient outcomes and avoiding adverse effects.
- The study contributes to a better understanding of Dravet syndrome's complex clinical and genetic landscape.
Objective:
Severe myoclonic epilepsy of infancy (SMEI), or Dravet syndrome, is a severe epileptic encephalopathy. This study aimed to investigate the clinical features and genetic diagnosis of SMEI.
Methods:
The electroclinical data and the mutation of SCN1A gene in 13 children with SMEI were analyzed.
Results:
Of the 13 children, 10 were males and 3 were females. Eight of them had family history of febrile seizures. The average age of seizure onset was 5.6 months, with a range of 2 to 9 months. The initial seizure was a febrile seizure in 9 patients (69%). Generalized or hemiclonic seizures were often triggered by fever. Eight patients had a history of febrile status. Afebrile seizures occurred from 2 months to 21 months of age. All patients went on to develop multiple seizure types. Generalized tonic clonus seizures (GTCS) were found in 11, partial seizures in 12, atypical absence in 10. Myoclonic seizures were presented in all patients. Twelve patients had 3 or more seizure types. Seizures of all patients had a characteristic of temperature sensitivity. The precipitating factors included fever, hot bath and vaccination. Nine patients (69%) had a history of status epilepticus. Delay in mental development was present in 11 cases, ataxia in 5 and pyramidal sign in 2. EEG was normal in most patients in the first year of life, followed by generalized, focal and multifocal discharges. Brain MRI was abnormal in 2 cases. Seizures were not completely controlled in all patients. Carbamazepine and lamotrigine aggravated seizures in some patients. SCN1A gene mutation was found in 10 cases, including seven missense mutations, two nonsense mutations and one frame shift mutation.
Conclusion:
The clinical features of SMEI were seizure onset within one year of age, first event is often a febrile seizure; multiple seizure types and mental delay occurred after the second year of life; seizures have a characteristic of temperature sensitivity; EEG was normal in the first year of life, followed by generalized, focal or multifocal discharges; early diagnosis by testing SCN1A mutation guides selection of antiepileptic drugs.
More Related Videos
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
01:13Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:22Epilepsy ll: Types
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Seizures l: Introduction
01:19Seizures ll: Types